NO944967L - Nye sekvenser av hepatitt C virus genotyper og anvendelse derav som terapeutiske og diagnostiske midler - Google Patents

Nye sekvenser av hepatitt C virus genotyper og anvendelse derav som terapeutiske og diagnostiske midler

Info

Publication number
NO944967L
NO944967L NO944967A NO944967A NO944967L NO 944967 L NO944967 L NO 944967L NO 944967 A NO944967 A NO 944967A NO 944967 A NO944967 A NO 944967A NO 944967 L NO944967 L NO 944967L
Authority
NO
Norway
Prior art keywords
hepatitis
therapeutic
diagnostic agents
new sequences
present
Prior art date
Application number
NO944967A
Other languages
English (en)
Norwegian (no)
Other versions
NO944967D0 (no
Inventor
Geert Maertens
Lieven Stuyver
Original Assignee
Innogenetics Sa Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Sa Nv filed Critical Innogenetics Sa Nv
Publication of NO944967D0 publication Critical patent/NO944967D0/no
Publication of NO944967L publication Critical patent/NO944967L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO944967A 1993-04-27 1994-12-21 Nye sekvenser av hepatitt C virus genotyper og anvendelse derav som terapeutiske og diagnostiske midler NO944967L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93401099 1993-04-27
EP93402019 1993-08-05
PCT/EP1994/001323 WO1994025601A2 (fr) 1993-04-27 1994-04-27 Nouvelles sequences de genotypes du virus de l'hepatite c et leur utilisation en tant qu'agents therapeutiques et diagnostiques

Publications (2)

Publication Number Publication Date
NO944967D0 NO944967D0 (no) 1994-12-21
NO944967L true NO944967L (no) 1994-12-21

Family

ID=26134679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944967A NO944967L (no) 1993-04-27 1994-12-21 Nye sekvenser av hepatitt C virus genotyper og anvendelse derav som terapeutiske og diagnostiske midler

Country Status (15)

Country Link
US (3) US6762024B2 (fr)
EP (4) EP1004670B1 (fr)
JP (5) JPH07508423A (fr)
CN (1) CN1108030A (fr)
AT (4) ATE551423T1 (fr)
AU (1) AU688323B2 (fr)
BR (1) BR9405334A (fr)
CA (2) CA2139100C (fr)
DE (1) DE69435023T2 (fr)
ES (1) ES2294779T3 (fr)
FI (1) FI946066A7 (fr)
NO (1) NO944967L (fr)
NZ (1) NZ266148A (fr)
SG (1) SG50563A1 (fr)
WO (1) WO1994025601A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE231557T1 (de) * 1991-11-21 2003-02-15 Common Services Agency Detektion des hepatis-c virus.
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6380376B1 (en) * 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US7258977B1 (en) * 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
US6762024B2 (en) 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
JP3751315B2 (ja) 1993-05-05 2006-03-01 コモン サーヴィシス エージェンシー Ｃ型肝炎ウイルス４、５及び６型
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
DE69526973T3 (de) * 1994-10-21 2010-01-07 Innogenetics N.V. Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
US5851759A (en) * 1996-04-19 1998-12-22 Chiron Corporation Heteroduplex tracking assay (HTA) for genotyping HCV
EP2298900A1 (fr) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Compositions et procédés de traitement de maladies intracellulaires
AU751362B2 (en) 1998-04-17 2002-08-15 Innogenetics N.V. Improved immunodiagnostic assays using reducing agents
DE19980730D2 (de) * 1998-04-28 2001-05-10 Wolfgang Bergter Radioimmunpharmaka zur Therapie der Hepatitis C
EP1113777B1 (fr) * 1998-06-09 2007-01-10 Andrea D. Branch Nouveaux peptides du virus de l'hepatite c et utilisations de ceux-ci
US7052830B1 (en) 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
BRPI0111731C1 (pt) * 2000-06-15 2021-07-27 Chiron Corp suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
CN100400101C (zh) * 2000-08-17 2008-07-09 特里帕普股份公司 包含病毒唑的疫苗及其使用方法
US6858590B2 (en) * 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) * 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
MD2149G2 (ro) * 2001-11-23 2003-10-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Primer oligonucleotidic pentru depistarea ARN-ului virusului hepatitei C
ES2321498T3 (es) * 2002-03-11 2009-06-08 Lab 21 Limited Metodos y composiciones para identificar y caracterizar la hepatitis c.
JP2005533855A (ja) 2002-07-24 2005-11-10 インターツェル・アクチェンゲゼルシャフト 病原性ウイルスからの別のリーディングフレームによりコードされる抗原
EP1537418A2 (fr) 2002-09-13 2005-06-08 Intercell AG Procede pour isoler des peptides du virus de l'hepatite c
AU2004224746B2 (en) 2003-03-24 2009-04-23 Valneva Austria Gmbh Improved vaccines
CA2530062A1 (fr) 2003-07-11 2005-01-20 Intercell Ag Vaccins contre le virus de l'hepatite c
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
JP5138230B2 (ja) * 2004-01-07 2013-02-06 サード・ウェーブ・テクノロジーズ・インク Ｃ型肝炎ウイルスの遺伝子型の決定方法
US20060162667A1 (en) * 2005-01-26 2006-07-27 Papadoyianis Ernest D Aquatic habitat and ecological tank
EP1888751A2 (fr) * 2005-05-25 2008-02-20 Tripep Ab Gene de fusion ns3/4a non structurel de l'hepatite c
US7465561B2 (en) 2005-06-30 2008-12-16 Roche Molecular Systems, Inc. Probes and methods for hepatitis C virus typing using single probe analysis
MD3300G2 (ro) * 2006-09-28 2007-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Primer oligonucleotidic pentru depistarea ARN-ului virusului hepatitei C
EP2463389A1 (fr) 2006-10-20 2012-06-13 Innogenetics N.V. Méthode d'analyse des variations de séquence dans la zone génomique NS5B du VHC
EP2121990A2 (fr) * 2006-10-20 2009-11-25 Innogenetics N.V. Méthode d'analyse des variations de séquence dans la zone génomique ns5b du vhc
EP2527474A1 (fr) 2006-10-20 2012-11-28 Innogenetics N.V. Méthodologie d'analyse des variations de séquence dans la zone génomique HCV NS3/4A
WO2009022939A1 (fr) * 2007-08-09 2009-02-19 Uchrezhdenie Rossiiskoi Akademii Nauk Institut Molekulyarnoi Biologii Im. V.A. Engelgardta Ran (Imb Ran) Procédé d'identification du génotype et du sous-type du virus de l'hépatite c sur une biopuce
WO2009022236A2 (fr) 2007-08-16 2009-02-19 Tripep Ab Plate-forme immunogène
RU2010121770A (ru) * 2007-10-30 2011-12-10 Интермьюн, Инк. (Us) Генотипирование и фенотипирование hcv
WO2009130588A2 (fr) * 2008-04-22 2009-10-29 Tripep Ab Plateforme immunogène
CN102378914B (zh) * 2009-03-30 2014-12-10 生物梅里埃公司 用于hcv检测的固体支持物
WO2013150450A1 (fr) * 2012-04-02 2013-10-10 Universidade Do Porto Fragments homologues du vhc, lignées cellulaires et applications associées
ES2832335T3 (es) * 2015-03-27 2021-06-10 Ortho Clinical Diagnostics Inc Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos
CN109642253A (zh) * 2016-08-02 2019-04-16 豪夫迈·罗氏有限公司 用于提高核酸的扩增和检测/定量的效率的辅助寡核苷酸

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
WO1989004669A1 (fr) * 1987-11-18 1989-06-01 Chiron Corporation Diagnostic et vaccins du virus d'hepatite non-a non-b
GB2236819B (en) * 1989-09-14 1993-07-14 Gen Motors France Dual master cylinder
WO1991004262A1 (fr) * 1989-09-15 1991-04-04 National Institute Of Health Of Japan Nouveaux isolats du virus de l'hepatite c
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
DE4040339C2 (de) 1989-12-18 1999-07-08 Wellcome Found Virales Agens
EP0435229A1 (fr) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. ADN d'un gène du virus de l'hépatite non-A non-B, son clonage et utilisation
WO1991014779A1 (fr) * 1990-03-28 1991-10-03 Mitsui Toatsu Chemicals, Incorporated Diagnostic du virus de l'hepatite
CA2044296A1 (fr) * 1990-06-12 1991-12-13 Hiroaki Okamoto Amorces d'oligonucleotides, leur application dans la detection haute-fidelite des virus de l'hepatite non-a et non-b
FI913068A7 (fi) 1990-06-25 1991-12-26 The Res Foundation For Microbial Ei-A-, ei-B-hepatiittiviruspartikkelit
ATE185350T1 (de) 1990-12-14 1999-10-15 Innogenetics Nv Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
EP0510952A1 (fr) * 1991-04-26 1992-10-28 Immuno Japan Inc. Primaires d'oligonucleotides et leur application de détection à haut détail de non-A, non-B hepatitis
RU2155228C2 (ru) 1991-05-08 2000-08-27 Чирон Корпорейшн Hcv геномные последовательности для диагностических и терапевтических целей
KR0185426B1 (ko) 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
EP0532167A3 (en) * 1991-08-09 1993-03-31 Immuno Japan Inc. Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
WO1993004088A1 (fr) * 1991-08-21 1993-03-04 Abbott Laboratories Depistage de l'hepatite c a l'aide d'antigenes recombines diriges contre la region ns1
DK0608261T3 (da) * 1991-09-13 2003-03-17 Chiron Corp Sammensætninger med immunreaktivt hepatitis C virus polypeptid
ATE231557T1 (de) * 1991-11-21 2003-02-15 Common Services Agency Detektion des hepatis-c virus.
DE69334357D1 (de) * 1992-11-27 2011-06-09 Innogenetics Nv Nachweis und Typisierung das Hepatitis C Virus (HCV) mittels 5'UTR und NS5 Nukleinsäuresequenzen
US6762024B2 (en) 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
UA46707C2 (uk) 1993-05-10 2002-06-17 Чірон Корпорейшн Спосіб типування вірусу гепатиту с (варіанти), набір поліпептидів (варіанти), реагент, що включає комбінацію поліпептидів, які містять типоспецифічні епітопи гепатиту с (варіанти)
JPH06319563A (ja) 1993-05-13 1994-11-22 Imuno Japan:Kk Ｃ型肝炎ウイルス遺伝子、オリゴヌクレオチド、並びにｃ型 肝炎ウイルス遺伝子型判定方法
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
JP2687852B2 (ja) * 1993-10-13 1997-12-08 日本電気株式会社 半導体メモリ装置

Also Published As

Publication number Publication date
EP0984067B1 (fr) 2012-04-04
US6762024B2 (en) 2004-07-13
EP0984067A3 (fr) 2000-09-27
EP0984067A2 (fr) 2000-03-08
DE69435023T2 (de) 2008-09-11
FI946066L (fi) 1994-12-23
US20030032005A1 (en) 2003-02-13
AU688323B2 (en) 1998-03-12
AU6722294A (en) 1994-11-21
CN1108030A (zh) 1995-09-06
FI946066A0 (fi) 1994-12-23
ATE373093T1 (de) 2007-09-15
ES2294779T3 (es) 2008-04-01
NO944967D0 (no) 1994-12-21
CA2662090A1 (fr) 1994-11-10
JPH07508423A (ja) 1995-09-21
ATE551423T1 (de) 2012-04-15
BR9405334A (pt) 1999-05-25
SG50563A1 (en) 1998-07-20
JP2004041207A (ja) 2004-02-12
EP0984068A3 (fr) 2000-09-20
EP0651807B1 (fr) 2007-09-12
EP1004670A3 (fr) 2000-09-20
ATE552340T1 (de) 2012-04-15
WO1994025601A2 (fr) 1994-11-10
ATE553201T1 (de) 2012-04-15
WO1994025601A3 (fr) 1995-03-02
NZ266148A (en) 1997-06-24
JP2002233389A (ja) 2002-08-20
JP2002233388A (ja) 2002-08-20
JP2004041206A (ja) 2004-02-12
DE69435023D1 (de) 2007-10-25
EP0984068B1 (fr) 2012-03-28
EP1004670A2 (fr) 2000-05-31
FI946066A7 (fi) 1994-12-23
US7157226B1 (en) 2007-01-02
CA2139100A1 (fr) 1994-11-10
CA2139100C (fr) 2009-06-23
EP0984068A2 (fr) 2000-03-08
US7195765B2 (en) 2007-03-27
EP0651807A1 (fr) 1995-05-10
US20030008274A1 (en) 2003-01-09
EP1004670B1 (fr) 2012-04-11

Similar Documents

Publication Publication Date Title
NO944967D0 (no) Nye sekvenser av hepatitt C virus genotyper og anvendelse derav som terapeutiske og diagnostiske midler
DE69334357D1 (de) Nachweis und Typisierung das Hepatitis C Virus (HCV) mittels 5'UTR und NS5 Nukleinsäuresequenzen
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
Gwack et al. Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein
CA2108466A1 (fr) Sequences genomiques du vhc pour le diagnostic et la therapie
RU93058449A (ru) Hcv геномные последовательности для диагностических и терапевтических целей
DE69837934D1 (de) Multisystemisches kümmerwuchssyndrom durch viren in schweine
NO905438L (no) Virusmiddel.
DK0770679T4 (da) HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf
EP1985705A3 (fr) Séquences de nucléotide de souches de pestivirus, polypeptides codées par ces séquences et utilisation correspondante pour le diagnostic et la prévention d'infections de pestivirus
WO2003020970A3 (fr) Nouveau genotype du virus de l'hepatite c, et son utilisation en tant qu'agent prophylactique, therapeutique et diagnostique
EP1878797A3 (fr) Peptides antigéniques pour le groupage du virus de l'hépatite C, kit comprenant ceux-ci et procédé de groupage les utilisant
WO2004014936A3 (fr) Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications.
DK0551275T3 (da) Non-A non-B sekvenser
Yoshioka et al. Deficiency of antibody response to hypervariable region of hepatitis C virus in patients with chronic hepatitis C
IT1270941B (it) Peptidi di hcv e loro usi.
KR950000880A (ko) 한국형 씨(c)형 간염 바이러스의 일종인 케이에이치씨브이-엘2(khcv-l2)의 전체 뉴클레오티드서열 및 이로부터 유추된 아미노산 서열
Kwag et al. Nucleotide Sequence Analyses of El Genes from Korean Hepatitis C Virus Isolates
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
KR950000881A (ko) 새로운 한국형 씨(C)형 간염 바이러스 씨디엔에이(cDNA) 절편의 뉴클레오티드 서열 및 이로부터 유추된 아미노산 서열

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application